logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
Cancer Communications 封面图

Cancer Communications

IF24.9
论文数840
被引数6883
期刊论文 840
发表时间
delete
NADPH Homeostasis and Regulation of Anti-tumor ImmunityNADPH稳态及抗肿瘤免疫的调控
deleteCancer Communications
IF24.9
delete2026-10-28
delete0
deleteOAAI
deleteTing-Ting Wang; Jin-Fei Lin; Yi-Chen Xie; Jun Dong; Chuan-Bo Xie; Huai-Qiang Ju
delete分享
delete收藏
PKN2 Drives Immunotherapy Resistance by Inducing Neutrophil Extracellular Trap-mediated T Cell Exclusion through the FOXC1 - CXCL8 Pathway in Esophageal Squamous Cell CarcinomaPKN2通过FOXC1-CXCL8通路诱导中性粒细胞胞外陷阱介导的T细胞排斥，从而驱动食管鳞状细胞癌的免疫治疗抵抗
deleteCancer Communications
IF24.9
delete2026-10-22
delete0
deleteOAAI
deleteHao Wu; Zhukai Chen; Zeyu Wang; Ziying Zhao; Hanyu Jiang; Zhaoxing Li; Shihan Zhang; Kang Fang; Zehua Zhang; Mingchuang Sun; Anqi Feng; Zhuyun Leng; Xiaoyuan Wang; Yuan Chu; Li Zhang; Lingnan He; Meidong Xu; Tao Chen
delete分享
delete收藏
Dirozalkib versus Crizotinib in Advanced ALK Inhibitor-Naïve ALK-Positive Non-Small Cell Lung Cancer : A Multicenter, Randomized Phase III TrialDirozalkib与Crizotinib在晚期ALK抑制剂初治ALK阳性非小细胞肺癌中的比较：一项多中心、随机III期试验
deleteCancer Communications
IF24.9
delete2026-10-20
delete0
deleteOAAI
deleteYing Liu; Xiangjiao Meng; Yan Yu; Jianhua Chen; Runxiang Yang; Laiyu Liu; Yanqiu Zhao; Ruifen Tian; Dianming Li; Ruiling Ning; Qingshan Li; Guowu Wu; Li Wang; Xianghui Duan; Xuejie Guo; Yan Hu; Weili Liu; Haifeng Liu
delete分享
delete收藏
Deciphering the mechanisms underlying therapeutic resistance in cancer through single-cell and spatial transcriptomics technologies: Current approaches and future perspectives通过单细胞和空间转录组学技术解析癌症治疗耐药性的机制：当前方法和未来展望
deleteCancer Communications
IF24.9
delete2026-10-19
delete0
deleteOAAI
deleteZikun Li; Qingning Chen; Mingyu Xiang; Zongyang Li; Xiaoyun He; Yuxiang He; Chunlin Ou
delete分享
delete收藏
SLC38A2-Driven Glutamine Metabolic Reprogramming Promotes Hypoxic Survival in GlioblastomaSLC38A2驱动的谷氨酰胺代谢重编程促进胶质母细胞瘤的缺氧生存
deleteCancer Communications
IF24.9
delete2026-10-19
delete0
deleteOAAI
deleteGang Li; Hao Xue; Yanhua Qi; Huize Xia; Zijie Gao; Boyan Li; Ziwen Pan; Bowen Feng; Chuanzheng Wang; Weiyang Ma; Ruochuan Li; Jiawei Qiu; Zhe Han; Zheyuan Chen; Weijie Tang; Qingtong Wang; Daiyan Wang; Leyang Hao; Junzhi Liu; Rongrong Zhao; Hongyu Zhao
delete分享
delete收藏
Combined Immunotherapy and Hybrid Dose-Fraction Radiotherapy for Driver-Negative Metastatic NSCLC: A Phase II Trial with Parallel Preclinical Studies联合免疫疗法和混合分割放射疗法治疗驱动基因阴性转移性非小细胞肺癌：一项伴有平行前临床研究的II期临床试验
deleteCancer Communications
IF24.9
delete2026-10-16
delete0
deleteOAAI
deleteZiye Li; Xiaoyang Li; Xiaoying Wei; Lejie Cao; Junqiang Zhang; Jianguo Wang; Yuan He; Anqi Hu; Bing Yan; Lei Liu; Congyu Wang; Hongxia Li; Ping Zeng; Jingjing Cheng; Anlin Wang; Jun Ma; Huailing Xia; Haibo Wu; Daqing Xia; Fengshou Jiang; Dan Xie; Dong Qian
delete分享
delete收藏
Targeting HDAC1 Overcomes Osimertinib Resistance and Triggers Immune Remodeling in Non-Small Cell Lung Cancer via the STAT3-CSN3-PD-L1 Axis靶向HDAC1克服奥希替尼耐药并通过STAT3-CSN3-PD-L1轴触发非小细胞肺癌的免疫重塑
deleteCancer Communications
IF24.9
delete2026-10-14
delete0
deleteOAAI
deleteLi Guan; Xinsheng Lei; Liyun Liu; Xinluo Song; Qian Liu; Hongrui Zhu; Qi He; Fan Sun; Houwen Lin
delete分享
delete收藏
Leveraging innate immune and metabolic cell death pathways in cancer therapies利用先天免疫和代谢性细胞死亡通路进行癌症治疗
deleteCancer Communications
IF24.9
delete2026-10-11
delete0
deleteOAAI
deleteYaqiu Wang; Thirumala-Devi Kanneganti
delete分享
delete收藏
SHMT2 K280 Succinylation Drives ICC Progression via S100A8+ Neutrophil-mediated ImmunosuppressionSHMT2 K280琥珀酰化通过S100A8+中性粒细胞介导的免疫抑制驱动ICC进展
deleteCancer Communications
IF24.9
delete2026-10-11
delete0
deleteOAAI
deleteLianxin Liu; Qingrui Zha; Cheng Cheng; Shuhang Liang; Yunguang Zhang; Weizhi Zhang; Shengwei Tao; Sitao Han; Linmao Sun; Wei Wei; Yufeng Liu; Kun Ma; Junhui Chu; Ning Zhang; Shumin Deng; Yao Liu; Jiabei Wang
delete分享
delete收藏
CAPTYN, a Blood-Based Machine Learning Model Predicting Clinical Benefit of Atezolizumab–Bevacizumab in Hepatocellular Carcinoma: Validation in IMbrave150 TrialCAPTYN，一种基于血液的机器学习模型预测阿替利珠单抗–贝伐珠单抗在肝细胞癌中的临床获益：IMbrave150试验中的验证
deleteCancer Communications
IF24.9
delete2026-09-29
delete0
deleteOAAI
deleteGae Hoon Jo; Sohyun Hwang; Bernhard Scheiner; Seonjeong Woo; Won Suk Lee; Beodeul Kang; Jung Sun Kim; Ho Yeong Lim; Chansik An; Dong Yun Kim; Inyoung Kim; Dong-hyuk Heo; Matthias Pinter; Beom Kyung Kim; Chan Kim; Hong Jae Chon
delete分享
delete收藏
Metabolic competition-driven antitumor immunity of glpX-deficient engineered Salmonella via glucose deprivation and STING activation in bladder cancerGLPX缺陷型工程沙门氏菌通过葡萄糖剥夺和STING激活介导的代谢竞争驱动的膀胱癌抗肿瘤免疫
deleteCancer Communications
IF24.9
delete2026-09-29
delete0
deleteOAAI
deleteLeyang Wu; Xinyue Qiao; Wanru Wang; Jiahui Qiu; Xiao Dong; Liyuan Qiao; Chengxuan Lei; Xiaoxin Zhang; Ying Sun; Chenyang Li; Bohao Wang; Zengzheng Du; Heng Liu; Zhengbing Lv; Xiaofeng Jiang; Zichun Hua
delete分享
delete收藏
An IGF2BP2–MYBL2–HMGB2 signaling axis promotes macrophage immune evasion in hepatocellular carcinoma​IGF2BP2–MYBL2–HMGB2信号轴促进肝癌巨噬细胞免疫逃逸
deleteCancer Communications
IF24.9
delete2026-09-20
delete0
deleteOAAI
deleteJin Woong Ha; Sang Yean Kim; Soyoung Jeon; Min Jeong Na; Jung Hwan Yoon; Suk Woo Nam
delete分享
delete收藏
Nectin-4-directed therapeutic repositioning augments anti-tumor efficacy in epithelial ovarian carcinomaNectin-4靶向药物重定位增强上皮性卵巢癌的抗肿瘤疗效
deleteCancer Communications
IF24.9
delete2026-09-17
delete0
deleteOAAI
deleteKatherine Xiaoyan Zhong; Runying Long; Jiangnan He; Yanqing Li; Ruiqian Zhang; Ling Shan Hung; Can Cui; Cheng Bao; Crystal Tang; Zhangping Xiao; Michelle Kwan Yee Siu; Tina Na Wei; Stephanie Si Liu; Yingjie Xu; Huijuan Yang; Kui Liu; Bryan Cho Wing Li; Haonan Lu; Karen Kar Loen Chan
delete分享
delete收藏
NBR1-Mediated Autophagic Degradation of YTHDF1 Curtails FDX1 Translation to Drive Concurrent Multikinase Inhibitor Resistance and Cuproptosis ToleranceNBR1介导的YTHDF1自噬降解抑制了FDX1的翻译，从而驱动了多激酶抑制剂耐药和铜死亡耐受的协同发生
deleteCancer Communications
IF24.9
delete2026-09-11
delete0
deleteOAAI
deleteWeikai Wang; Xin Jiang; Xiaona Chen; Kaiyu Liang; Miaoqin Chen; Kaizhong Lu; Qi Wei; Yuchen Wu; Liyuan Zhu; Yuan Chen; Tianlun Hou; Jingfeng Luo; Chentao Li; Xian Wang; Hongchuan Jin; Lifeng Feng
delete分享
delete收藏
Neutrophil Senescence Induced by Tumor-Derived HMGB1 Promotes Hepatocellular Carcinoma Progression through Neutrophil Extracellular Trap-Mediated Suppression of CD8+ T Cell Immunity肿瘤来源的HMGB1诱导的中性粒细胞衰老通过中性粒细胞胞外陷阱介导的CD8+ T细胞免疫抑制促进肝细胞癌进展
deleteCancer Communications
IF24.9
delete2026-09-11
delete0
deleteOAAI
deleteYaqian Duan; Shan Yu; Xuanyi Wang; Rong Wu; Yuqing Zhao; Xuehua Kong; Shiyu Cao; Dan Xiang; Rui Wu; Jingying Zhou; Yang Luo; Liang Duan
delete分享
delete收藏
Targeting TREM2+ macrophages reprograms the tumor microenvironment and enhances PD-1 blockade efficacy in intrahepatic cholangiocarcinoma靶向TREM2+巨噬细胞重编程肿瘤微环境并增强PD-1阻断疗法在肝内胆管癌中的疗效
deleteCancer Communications
IF24.9
delete2026-09-09
delete0
deleteOAAI
deleteyao Li; Hongwen Liu; Lei Xu; Lili Huang; Hui Xue; Tao Lu; Yuxuan Lin; Liangrui Chen; Jianwei Liu; Shilei Bai; Yong Xia; Lei Wang; Hui Dong; Feng Shen; Kui Wang
delete分享
delete收藏
The PROM1+SMAD5+ Tumor-Initiating Subpopulation Shapes Premetastatic Niches through Spatial Multi-Omics Landscapes in HER2-Positive Breast CancerPROM1+SMAD5+肿瘤起始亚群通过空间多组学景观重塑HER2阳性乳腺癌的转移前微环境
deleteCancer Communications
IF24.9
delete2026-09-09
delete0
deleteOAAI
deleteHuijing Yin; Wei Wang; Jing Ge; Guangjian Fan; Jichao Shi; Ye Tian; Deping Kong; Fanyi Zhang; Jing Wei; Hongrui Zhan; Zhenyu Xu; Jintong Ge; Shuwei Wang; Zhiming Zhang; Yunna Zheng; Zhifa Zhu; Qingzhen Zi; Xiaohua Yao; Yanting Ding; Bo Song; Ruizhi Li; Liming Fan; Hao Yin; Yinghao Jiang; Shaoqian Zhang; Xingning Fu; Jing Wang; Yan Zhou; Haihua Xue; Yannan Qiu; Ling Ge; Yuqin Yang; Yinhui Jin; Binbin Lou; Shuning Ding; Tao Zhang; Denghui Wei; Li Zhu
delete分享
delete收藏
GULP1 Fuels Resistance to PD-1 Blockade through Lipid-Mediated Metabolic Reprogramming of Tumor-Associated Macrophages in Gastric CancerGULP1 通过脂质介导的肿瘤相关巨噬细胞代谢重编程促进胃癌对PD-1阻断的抵抗
deleteCancer Communications
IF24.9
delete2026-08-31
delete0
deleteOAAI
deleteZihao Zhang; Wenxin Xu; Kuan Yu; Anran Bao; Yifan Cao; Mincheng Yu; Qiang Yu; Yufei Zhao; Liang Gong; Peiyi Xie; Zhenbin Shen; Jing Qin
delete分享
delete收藏
Lactylation of Mutation-Prone RAS Residues Mimics Oncogenic Mutations and Drives Constitutive Activation突变倾向的RAS残基的乳酰化模拟致癌突变并驱动组成性激活
deleteCancer Communications
IF24.9
delete2026-08-26
delete0
deleteOAAI
deleteRuocen Liao; Chenglong Ma; Xingyu Chen; Longchang Bai; Qianhua Cao; Yu Zhang; Chenfang Dong
delete分享
delete收藏
The Five-Decade Journey of Small Cell Lung Cancer小细胞肺癌的五十年历程
deleteCancer Communications
IF24.9
delete2026-08-25
delete0
deleteOAAI
deletesheng hu; Runzhi Chen; Chang Xue; Yi Zhong; Qing Huang; Qianyu Fan; Yuanxiang Li; Jingyi Wu; Shuang Dong; Xiaoyu Li; Tianlin Xiao
delete分享
delete收藏